- Type / Class
- Equity / Common Stock
- Shares outstanding
- 29,067,614
- Total 13F shares
- 20,551,109
- Share change
- +430,019
- Total reported value
- $1,367,525,309
- Put/Call ratio
- 66%
- Price per share
- $66.54
- Number of holders
- 129
- Value change
- +$24,889,158
- Number of buys
- 71
- Number of sells
- 70
Quarterly Holders Quick Answers
What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501147102:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
6.8%
|
1,978,284
|
$138,381,000 | — | 31 Dec 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
6.4%
|
1,856,156
|
$129,838,000 | — | 31 Dec 2021 | |
| Redmile Group, LLC |
13F
|
Company |
6.3%
|
1,820,898
|
$127,372,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.5%
|
1,605,496
|
$112,303,000 | — | 31 Dec 2021 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
4%
|
1,173,863
|
$82,112,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
1,023,610
|
$71,602,000 | — | 31 Dec 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.8%
|
807,735
|
$56,501,000 | — | 31 Dec 2021 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
2.7%
|
771,250
|
$53,949,000 | — | 31 Dec 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
2.6%
|
753,680
|
$52,719,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
701,801
|
$49,091,000 | — | 31 Dec 2021 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
2.4%
|
701,403
|
$49,063,000 | — | 31 Dec 2021 | |
| Artal Group S.A. |
13F
|
Company |
2.4%
|
700,000
|
$48,965,000 | — | 31 Dec 2021 | |
| First Light Asset Management, LLC |
13F
|
Company |
2.3%
|
680,170
|
$47,578,000 | — | 31 Dec 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.6%
|
475,000
|
$33,226,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
329,926
|
$23,078,000 | — | 31 Dec 2021 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.79%
|
228,437
|
$15,979,000 | — | 31 Dec 2021 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.78%
|
225,727
|
$15,790,000 | — | 31 Dec 2021 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.72%
|
208,826
|
$14,722,000 | — | 31 Dec 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.69%
|
199,629
|
$13,964,000 | — | 31 Dec 2021 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.66%
|
191,311
|
$13,382,000 | — | 31 Dec 2021 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.64%
|
185,809
|
$12,997,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.63%
|
183,559
|
$12,840,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.52%
|
150,641
|
$10,538,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
139,618
|
$9,767,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.38%
|
110,993
|
$7,763,000 | — | 31 Dec 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.37%
|
108,511
|
$7,592,000 | — | 31 Dec 2021 | |
| S Squared Technology, LLC |
13F
|
Company |
0.33%
|
95,215
|
$6,660,000 | — | 31 Dec 2021 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.31%
|
90,000
|
$6,296,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
83,451
|
$5,837,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.27%
|
78,178
|
$5,468,000 | — | 31 Dec 2021 | |
| Verition Fund Management LLC |
13F
|
Company |
0.26%
|
76,114
|
$5,324,000 | — | 31 Dec 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.21%
|
61,429
|
$4,297,000 | — | 31 Dec 2021 | |
| CWM, LLC |
13F
|
Company |
0.21%
|
59,935
|
$4,192,000 | — | 31 Dec 2021 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
59,000
|
$4,127,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.18%
|
53,153
|
$3,718,000 | — | 31 Dec 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.18%
|
52,470
|
$3,670,000 | — | 31 Dec 2021 | |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC |
13F
|
Company |
0.18%
|
50,922
|
$3,562,000 | — | 31 Dec 2021 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
46,670
|
$3,265,000 | — | 31 Dec 2021 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.15%
|
45,000
|
$3,148,000 | — | 31 Dec 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.14%
|
39,447
|
$2,759,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.13%
|
38,745
|
$2,710,000 | — | 31 Dec 2021 | |
| Swiss National Bank |
13F
|
Company |
0.13%
|
38,400
|
$2,686,000 | — | 31 Dec 2021 | |
| DnB Asset Management AS |
13F
|
Company |
0.12%
|
35,640
|
$2,493,018 | — | 31 Dec 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.12%
|
34,888
|
$2,440,000 | — | 31 Dec 2021 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.12%
|
34,867
|
$2,439,000 | — | 31 Dec 2021 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.12%
|
34,816
|
$2,435,000 | — | 31 Dec 2021 | |
| Parallel Advisors, LLC |
13F
|
Company |
0.12%
|
34,036
|
$2,381,000 | — | 31 Dec 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.11%
|
32,493
|
$2,273,000 | — | 31 Dec 2021 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.1%
|
30,237
|
$2,115,000 | — | 31 Dec 2021 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.1%
|
28,819
|
$2,016,000 | — | 31 Dec 2021 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock (KRYS) as of Q1 2022
As of 31 Mar 2022,
Krystal Biotech, Inc. - Common Stock (KRYS) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,551,109 shares.
The largest 10 holders included
FMR LLC, Redmile Group, LLC, Point72 Asset Management, L.P., BlackRock Inc., LORD, ABBETT & CO. LLC, STATE STREET CORP, VANGUARD GROUP INC, Avoro Capital Advisors LLC, Frazier Life Sciences Management, L.P., and BAKER BROS. ADVISORS LP.
This page lists
129
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
135
Q1 2022 holders
129
Holder diff
-6
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.